The Centers for Disease Control and Prevention's vaccine advisory committee on Friday indefinitely postponed its planned vote on whether to stop recommending the hepatitis B vaccine for newborns . The Advisory Committee on Immunization Practices, called ACIP, is expected to vote on the COVID-19 vaccine is still expected later Friday. It's not clear exactly what the advisors will vote on, but the discussion may include the FDA's recent narrowing of COVID-19 vaccine approvals to a smaller group of Americans -- those over 65 or with underlying medical conditions. On Thursday, the group voted to narrow existing recommendations for the combined MMRV shot that protects against measles, mumps, rubella and chickenpox. A "yes" vote on the hepatitis B vaccine would have recommended that the first do

See Full Page